GlobeNews Wire

Shiny Smile Veneers 2026: Claims Examined, Pricing Verified & What Consumers Should Confirm Before Buying

New York City, NY, March 14, 2026 (GLOBE NEWSWIRE) -- For anyone who has been thinking about fixing their smile,…

2 weeks ago

Lean Drops Announces USA & Canada Debut: Introducing LeanDrops Weight Management Liquid Formula

New York City, NY, March 14, 2026 (GLOBE NEWSWIRE) -- Lean Drops, an innovative liquid dietary supplement targeting metabolic function…

2 weeks ago

Sugar Harmony (2026 CONSUMER REPORT): Tainted Supplement Warning Issued as “Glucose Reset Ritual” Goes Viral

New York City, NY, March 14, 2026 (GLOBE NEWSWIRE) -- Sugar Harmony: SugarHarmony Research has issued a consumer safety notice…

2 weeks ago

First Ever Real-World Evidence of Eversense 365 Presented at ATTD Demonstrates Sustained Performance and Positive Impact Throughout One-Year of Wear

March 14, 2026 10:15 ET  | Source: Senseonics Holdings, Inc. New data shows positive real-world impact of the world’s first…

2 weeks ago

Biomea Fusion Presents Phase II COVALENT-111 Data in Type 2 Diabetes at the 19th International Conference on Advanced Technologies & Treatments for Diabetes 2026

SAN CARLOS, Calif., March 14, 2026 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea,” “Biomea Fusion,” or the “Company”) (Nasdaq: BMEA),…

2 weeks ago

AgelessRx 2026: Longevity Telehealth Platform Overview Treatments, Pricing, Compounded Medications, and What Prospective Patients Should Know

Ann Arbor, MI, March 13, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational and educational purposes only and…

2 weeks ago

InflaRx Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement

JENA, Germany, March 13, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting…

2 weeks ago

Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization

Lead investor confirmed his intention to maintain his current shareholdings.Company does not anticipate using more than 1% of our authorized…

2 weeks ago

Novartis Cosentyx receives FDA approval for pediatric patients aged 12+ with moderate to severe hidradenitis suppurativa

Cosentyx is the only IL-17A inhibitor approved for this population, and the first differentiated mechanism in nearly a decade1-3 HS often emerges around…

2 weeks ago

Microvast Schedules Fourth Quarter Earnings Call

March 13, 2026 15:00 ET  | Source: Microvast Holdings, Inc. STAFFORD, Texas, March 13, 2026 (GLOBE NEWSWIRE) -- Microvast Holdings,…

2 weeks ago